VIRTRA SYSTEMS, INC. ____________________ This offering consists of up to $450,000 of the Company’s Convertible Debentures convertible into the Company’s Common Stock. ____________________ SUBSCRIPTION AGREEMENT ___________________ SUBSCRIPTION PROCEDURES
Exhibit
10.1
____________________
VIRTRA SYSTEMS, INC.
____________________
This offering consists of up to $450,000 of the Company’s Convertible
Debentures convertible into the
Company’s Common Stock.
VIRTRA SYSTEMS, INC.
____________________
This offering consists of up to $450,000 of the Company’s Convertible
Debentures convertible into the
Company’s Common Stock.
___________________
SUBSCRIPTION PROCEDURES
SUBSCRIPTION PROCEDURES
Convertible Debentures of VirTra Systems, Inc. (the “Company”) are being offered (the “Debentures”). This offering is being made in accordance with the exemptions from registration provided for under Section 4(2) of the Securities Act of 1933, as amended (the “1933 Act”) and Rule 506 of Regulation D promulgated under the 1933 Act.
In order to purchase Debentures, each subscriber must complete and execute a questionnaire (the “Questionnaire”) and a subscription agreement (the “Subscription Agreement”). In addition, the subscriber must make a payment to an escrow fund for the amount being purchased. All subscriptions are subject to acceptance by the Company, which shall not occur until the Company has returned the signed Company Signature Page.
The Questionnaire is designed to enable the Purchaser to demonstrate the minimum legal requirements under federal and state securities laws to purchase the Debentures. The Signature Page for the Questionnaire and the Subscription Agreement contain representations relating to the subscription and should be reviewed carefully by each subscriber.
If you are a foreign person or foreign entity, you may be subject to a withholding tax equal to 30% of any dividends paid by the Company. In order to eliminate or reduce such withholding tax you must submit a properly executed I.R.S. Form 4224 (Exemption from Withholding of Tax on Income Effectively Connected with the Conduct of a Trade or Business in the United States) or I.R.S. Form 1001 (Ownership Exemption or Reduced Trade Certificate), claiming exemption from withholding or eligibility for treaty benefits in the form of a lower rate of withholding tax on interest or dividends.
Payment must be made by wire transfer to Xxxxxx X. XxXxxxx, Esq. (the “Escrow Agent”) per the wire instructions that will be established. In the event of a termination of the offering or the rejection of a subscription, subscription funds will be returned by the Escrow Agent without interest or charges.
THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SUCH LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER SUCH LAWS PURSUANT TO REGISTRATION OR AN EXEMPTION THEREFROM. THE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION OR ANY OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE ACCURACY OR ADEQUACY OF THE OFFERING MATERIALS. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.
To: VIRTRA SYSTEMS, INC.
This Subscription Agreement is made between VIRTRA SYSTEMS, INC., a Texas corporation, (the “Company”), and the undersigned prospective purchaser (“Purchaser”) who is subscribing hereby for the Company’s convertible debentures (the “Debentures”). This subscription is submitted to you in accordance with and subject to the terms and conditions described in this Subscription Agreement, together with any Exhibits thereto, relating to an offering (the “Offering”) of up to $450,000 of Debentures. The Offering is limited to accredited investors and is made in accordance with the exemptions from registration provided for under Section 4(2) of the 1933 Act and Rule 506 of Regulation D promulgated under the 1933 Act (“Regulation D”).
1. SUBSCRIPTION.
(a) The Purchaser hereby irrevocably subscribes for and agrees to purchase that amount of Debentures as stated on the signature page upon the terms set forth in this Subscription Agreement. The Debentures shall pay a 5% cumulative interest, payable in arrears at the time of each conversion, in cash or in common stock of the Company, $.005 par value (“Common Stock”), at the Company’s option. If paid in Common Stock, the number of shares of the Company’s Common Stock to be received shall be determined by dividing the amount of the accrued and unpaid interest by the conversion price as of the time of conversion under the terms of the Debenture. If the dividend is to be paid in cash, the Company shall make such payment within five (5) business days of the conversion date. If the dividend is to be paid in Common Stock, said Common Stock shall be delivered to the Purchaser, or per Purchaser’s instructions, within five (5) business days of the conversion date. The Debentures are subject to automatic conversion at the end of three (3) years from the date of issuance at which time all Debentures outstanding will be automatically converted based upon the terms set forth in the Debenture. The closing shall be deemed to have occurred on the date funds, less commitment fees, escrow fees and attorney fees, are received by the Company (the “Closing Date”). The initial closing shall be held not later than the fifth day after execution of this Agreement, the Registration Rights Agreement and the Escrow Agreement.
(b) Upon receipt by the Company of the requisite payment for the Debentures being purchased, the Debentures so purchased will be forwarded by the Escrow Agent to the Purchaser or its broker, as listed on the signature page, and the name of such Purchaser will be registered on the Debenture transfer books of the Company as the record owner of such Debentures. The Escrow Agent shall not be liable for any action taken or omitted by him in good faith and in no event shall the Escrow Agent be liable or responsible except for the Escrow Agent’s own gross negligence or willful misconduct. The Escrow Agent has made no representations or warranties in connection with this transaction and has not been involved in the negotiation of the terms of this Agreement or any matters relative thereto. The Company and Purchaser each agree to indemnify and hold harmless the Escrow Agent from and with respect to any suits, claims, actions or liabilities arising in any way out of this transaction including the obligation to defend any legal action brought which in any way arises out of or is related to this Agreement.
(c) As long as the Purchaser owns the Debenture, the Purchaser shall have the right to change the terms for the balance of the Debenture it then holds, to match the terms of any other offering of convertible securities made by the Company.
(d) The Purchaser shall receive Warrants (substantially in the form attached hereto as Exhibit F) to Purchase 5,556 shares of Common Stock per $5,000 invested, on a pro rata basis. The exercise price shall be 200% of the closing bid price on the Closing Date. The Warrants shall have a cashless exercise provision and have a three (3) year term.
(e) Conditions Precedent. The following shall be conditions precedent to closing and release of funds from escrow: (i) the Company and an investor(s) have signed documentation for an $5,000,000 equity credit line financing; and (ii) the Company shall have executed and delivered the Registration Rights Agreement and the Escrow Agreement.
(f) The Purchasers shall fund $250,000 upon the initial closing and an additional $200,000 on a pro-rata basis not later than three (3) business days following the date the registration statement covering this Offering is declared effective.
2. REPRESENTATIONS AND WARRANTIES.
The
Purchaser hereby represents and warrants to, and agrees with, the Company as
follows:
(a) The
Purchaser has been furnished with, and has carefully read the applicable form of
Registration Rights Agreement annexed hereto as Exhibit B (the "Registration
Rights Agreement"), and the Debenture annexed hereto as Exhibit C and is
familiar with and understands the terms of the Offering. With respect to tax and
other economic considerations involved in his investment, the Purchaser is not
relying on the Company. The Purchaser has carefully considered and has, to the
extent the Purchaser believes such discussion necessary, discussed with the
Purchaser 's professional legal, tax, accounting and financial advisors the
suitability of an investment in the Company, by purchasing the Debentures, for
the Purchaser 's particular tax and financial situation and has determined that
the investment being made by the Purchaser is a suitable investment for the
Purchaser.
(b) The
Purchaser acknowledges that all documents, records, and books pertaining to this
investment which the Purchaser has requested have been made available for
inspection or the Purchaser has had access thereto.
(c) The
Purchaser has had a reasonable opportunity to ask questions of and receive
answers from a person or persons acting on behalf of the Company concerning the
Offering and if such opportunity was taken, all such questions have been
answered to the full satisfaction of the Purchaser.
(d) The
Purchaser will not sell, or otherwise dispose of the Debentures or the Common
Stock issued upon conversion of the Debentures without registration under the
1933 Act or applicable state securities laws or compliance with an exemption
therefrom. The Debentures have not been registered under the 1933 Act or under
the securities laws of any state. Resales of the Common Stock underlying the
Debentures or issued in payment of accrued interest on the Debentures are to be
registered by the Company pursuant to the terms of the Registration Rights
Agreement attached hereto as Exhibit B and incorporated herein and made a part
hereof.
(e) The
Purchaser recognizes that an investment in the Debentures involves substantial
risks, including loss of the entire amount of such investment. Further, the
Purchaser has carefully read and considered the schedule entitled Pending
Litigation matters attached hereto as Schedule 3(h).
(f) The
Purchaser acknowledges that each certificate representing the Debentures (and
the shares of Common Stock issued upon conversion of the Debentures, unless
registered) or in payment of dividends on the Debentures shall be stamped or
otherwise imprinted with a legend substantially in the following form:
THE
SECURITIES EVIDENCED BY THIS CERTIFICATE MAY NOT BE OFFERED OR SOLD,
TRANSFERRED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT (i) PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, (ii) TO THE EXTENT APPLICABLE, PURSUANT TO RULE 144 UNDER THE ACT (OR
ANY SIMILAR RULE UNDER SUCH ACT RELATING TO THE DISPOSITION OF SECURITIES), OR
(iii) PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER SUCH
ACT.
If
Purchaser sends a Notice of Conversion and indicates on said notice that the
conversion is for an immediate sale, and provided a registration statement under
the Securities Act of 1933 is in effect as to the sale, then in such event the
Company shall have its transfer agent send Purchaser the appropriate number of
shares of Common Stock without restrictive legends and not subject to stop
transfer instructions.
(g) The
Purchaser acknowledges and agrees that it shall not be entitled to seek any
remedies with respect to the Offering from any party other than the
Company.
(h) If
this Subscription Agreement is executed and delivered on behalf of a
corporation: (i) such corporation has the full legal right and power and all
authority and approval required (a) to execute and deliver, or authorize
execution and delivery of, this Subscription Agreement and all other instruments
(including, without limitation, the Registration Rights Agreement) executed and
delivered by or on behalf of such corporation in connection with the purchase of
the Debentures and (b) to purchase and hold the Debentures; and (ii) the
signature of the party signing on behalf of such corporation is binding upon
such corporation.
(i) The
Purchaser is not subscribing for the Debentures as a result of, or pursuant to,
any advertisement, article, notice or other communication published in any
newspaper, magazine or similar media or broadcast over television or radio or
presented at any seminar or meeting.
(j) The Purchaser is purchasing the Debentures for its own account for
investment, and not with a view toward the resale or distribution thereof,
except pursuant to sales registered or exempted from registration under the 0000
Xxx. The Purchaser has not offered or sold any portion of the Debentures being
acquired nor does the Purchaser have any present intention of dividing the
Debentures with others or of selling, distributing or otherwise disposing of any
portion of the Debentures either currently or after the passage of a fixed or
determinable period of time or upon the occurrence or non-occurrence of any
predetermined event or circumstance in violation of the 1933 Act provided,
however, that by making the representations herein, Purchaser does not agree to
hold any of the Debentures for any minimum or other specific term and reserves
the right to dispose of the Debentures at any time in accordance with or
pursuant to a registration statement or an exemption under the 1933 Act.
Purchaser is neither an underwriter of, nor a dealer in, the Debentures or the
Common Stock issuable upon conversion thereof or upon the payment of dividends
thereon and is not participating in the distribution or resale of the Debentures
or the Common Stock issuable upon conversion or exercise thereof. Except as
provided in the Registration Rights Agreement, the Company has no obligation to
register the Common Stock underlying Debentures and the Common Stock that may be
issued in lieu of cash dividends.
(k) The
Purchaser or the Purchaser's representatives, as the case may be, has such
knowledge and experience in financial, tax and business matters so as to enable
the Purchaser to utilize the information made available to the Purchaser in
connection with the Offering to evaluate the merits and risks of an investment
in the Debentures and to make an informed investment decision with respect
thereto.
3. REPRESENTATIONS
AND WARRANTIES OF THE COMPANY.
Except as set forth in the Schedules attached hereto, the Company represents and warrants to the Purchaser that:
a. Organization and Qualification. The Company and its “SUBSIDIARIES” (which for purposes of this Subscription Agreement means any entity in which the Company, directly or indirectly, owns capital stock or holds an equity or similar interest) (a complete list of which is set forth in Schedule 3(a)) are corporations duly organized and validly existing in good standing under the laws of the respective jurisdictions of their incorporation, and have the requisite corporate power and authorization to own their properties and to carry on their business as now being conducted. Each of the Company and its Subsidiaries is duly qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing would not have a Material Adverse Effect. As used in this Subscription Agreement, “MATERIAL ADVERSE EFFECT” means any material adverse effect on the business, properties, assets, operations, results of operations, financial condition or prospects of the Company and its Subsidiaries, if any, taken as a whole, or on the transactions contemplated hereby or by the agreements and instruments to be entered into in connection herewith, or on the authority or ability of the Company to perform its obligations under the Transaction Documents (as defined in Section 3(b)below).
b. Authorization; Enforcement; Compliance with Other Instruments. (i) The Company has the requisite corporate power and authority to enter into and perform this Subscription Agreement, the Registration Rights Agreement and the Escrow Agreement, and each of the other agreements entered into by the parties hereto in connection with the transactions contemplated by this Subscription Agreement (collectively, the “TRANSACTION DOCUMENTS”), and to issue the Debentures in accordance with the terms hereof and thereof, (ii) the execution and delivery of the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby, including without limitation the reservation for issuance and the issuance of the Debentures pursuant to this Subscription Agreement, have been duly and validly authorized by the Company's Board of Directors and no further consent or authorization is required by the Company, its Board of Directors, or its shareholders, (iii) the Transaction Documents have been duly and validly executed and delivered by the Company, and (iv) the Transaction Documents constitute the valid and binding obligations of the Company enforceable against the Company in accordance with their terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of creditors' rights and remedies.
c. Capitalization. As of the date hereof, the authorized capital stock of the Company consists of (i) 100,000,000 shares of Common Stock, of which as of the date hereof, approximately 35,606,931 shares are issued and outstanding, 2,000,000 shares of Preferred Stock of which none are issued and outstanding and approximately 3,626,703 (as of July 1, 2002) shares of Common Stock are issuable upon the exercise of options, warrants and conversion rights. All of such outstanding shares have been, or upon issuance will be, validly issued and are fully paid and nonassessable. Except as disclosed in Schedule 3(c) which is attached hereto and made a part hereof, (i) no shares of the Company's capital stock are subject to preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by the Company, (ii) there are no outstanding debt securities, (iii) there are no outstanding shares of capital stock, options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional shares of capital stock of the Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its Subsidiaries, (iv) there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any of their securities under the 1933 Act (except the Registration Rights Agreement), (v) there are no outstanding securities of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or any of its Subsidiaries, (vi) there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance of the Securities as described in this Subscription Agreement, (vii) the Company does not have any stock appreciation rights or "phantom stock" plans or agreements or any similar plan or agreement and (viii) there is no dispute as to the class of any shares of the Company's capital stock. The Company has furnished to the Purchaser, or the Purchaser has had access through XXXXX to, true and correct copies of the Company's Articles of Incorporation, as in effect on the date hereof (the “ARTICLES OF INCORPORATION”), and the Company's By-laws, as in effect on the date hereof (the “BY-LAWS ‘), and the terms of all securities convertible into or exercisable for Common Stock and the material rights of the holders thereof in respect thereto.
d. Issuance of
Debentures. A sufficient number of Debentures issuable pursuant to this
Subscription Agreement, but not more than 19.99% of the shares of Common Stock
outstanding as of the date hereof (if the Company becomes listed on Nasdaq or
the American Stock Exchange), has been duly authorized and reserved for issuance
pursuant to this Subscription Agreement. Upon issuance in accordance with this
Subscription Agreement, the Debentures will be validly issued, fully paid and
nonassessable and free from all taxes, liens and charges with respect to the
issue thereof. In the event the Company cannot register a sufficient number of
shares of Common Stock, due to the remaining number of authorized shares of
Common Stock being insufficient, the Company will use its best efforts to
register the maximum number of shares it can based on the remaining balance of
authorized shares and will use its best efforts to increase the number of its
authorized shares as soon as reasonably practicable.
e. No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company of the transactions contemplated hereby and thereby will not (i) result in a violation of the Articles of Incorporation, any Certificate of Designations, Preferences and Rights of any outstanding series of preferred stock of the Company or the By-laws or (ii) conflict with, or constitute a material default (or an event which with notice or lapse of time or both would become a material default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material agreement, contract, indenture mortgage, indebtedness or instrument to which the Company or any of its Subsidiaries is a party, or result in a violation of any law, rule, regulation, order, judgment or decree, including United States federal and state securities laws and regulations and the rules and regulations of the principal securities exchange or trading market on which the Common Stock is traded or listed (the “Principal Market”), applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected. Except as disclosed in Schedule 3(e), neither the Company nor its Subsidiaries is in violation of any term of, or in default under, the Articles of Incorporation, any Certificate of Designations, Preferences and Rights of any outstanding series of preferred stock of the Company or the By-laws or their organizational charter or by-laws, respectively, or any contract, agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or order or any statute, rule or regulation applicable to the Company or its Subsidiaries, except for possible conflicts, defaults, terminations, amendments, accelerations, cancellations and violations that would not individually or in the aggregate have a Material Adverse Effect. The business of the Company and its Subsidiaries is not being conducted, and shall not be conducted, in violation of any law, statute, ordinance, rule, order or regulation of any governmental authority or agency, regulatory or self-regulatory agency, or court, except for possible violations the sanctions for which either individually or in the aggregate would not have a Material Adverse Effect. Except as specifically contemplated by this Subscription Agreement and as required under the 1933 Act, the Company is not required to obtain any consent, authorization, permit or order of, or make any filing or registration (except the filing of a registration statement) with, any court, governmental authority or agency, regulatory or self-regulatory agency or other third party in order for it to execute, deliver or perform any of its obligations under, or contemplated by, the Transaction Documents in accordance with the terms hereof or thereof. All consents, authorizations, permits, orders, filings and registrations which the Company is required to obtain pursuant to the preceding sentence have been obtained or effected on or prior to the date hereof and are in full force and effect as of the date hereof. Except as disclosed in Schedule 3(e), the Company and its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing. The Company is not, and will not be, in violation of the listing requirements of the Principal Market as in effect on the date hereof and on each of the Closing Dates and is not aware of any facts which would reasonably lead to delisting of the Common Stock by the Principal Market in the foreseeable future.
f. SEC Documents; Financial Statements. Since January 1, 2002, the Company has filed all reports, schedules, forms, statements and other documents required to be filed by it with the Securities and Exchange Commission (“SEC”) pursuant to the reporting requirements of the Securities and Exchange Act of 1934 (“1934 Act”) (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the "SEC DOCUMENTS"). The Company has delivered to the Purchaser or its representatives, or they have had access through XXXXX, to true and complete copies of the SEC Documents. As of their respective dates, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. As of their respective dates, the financial statements of the Company included in the SEC Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial statements have been prepared in accordance with generally accepted accounting principles, consistently applied, during the periods involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material respects the financial position of the Company as of the dates thereof and the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). No other written information provided by or on behalf of the Company to the Purchaser which is not included in the SEC Documents, including, without limitation, information referred to in Section 3(d) of this Subscription Agreement, contains any untrue statement of a material fact or omits to state any material fact necessary to make the statements therein, in the light of the circumstance under which they are or were made, not misleading.
g. Absence of Certain Changes. Except as disclosed in Schedule 3(g) or the SEC Documents filed at least five (5) days prior to the date hereof, since May 15, 2001, there has been no change or development in the business, properties, assets, operations, financial condition, results of operations or prospects of the Company or its Subsidiaries which has had or reasonably could have a Material Adverse Effect. The Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant to any bankruptcy law nor does the Company or its Subsidiaries have any knowledge or reason to believe that its creditors intend to initiate involuntary bankruptcy proceedings.
h. Absence of Litigation. Except as set forth in Schedule 3(h), there is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of Company or any of its Subsidiaries, threatened against or affecting the Company, the Common Stock or any of the Company's Subsidiaries or any of the Company's or the Company's Subsidiaries' officers or directors in their capacities as such, in which an adverse decision could have a Material Adverse Effect.
i. Acknowledgment Regarding the Purchase of Debentures. The Company acknowledges and agrees that the Purchaser is acting solely in the capacity of arm's length investor with respect to the Transaction Documents and the transactions contemplated hereby and thereby. The Company further acknowledges that the Purchaser is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby and any advice given by the Purchaser or any of its respective representatives or agents in connection with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to the Purchaser's purchase of the Debentures. The Company further represents to the Purchaser that the Company's decision to enter into the Transaction Documents has been based solely on the independent evaluation by the Company and its representatives.
j. Intentionally omitted.
k. Employee Relations. Neither the Company nor any of its Subsidiaries is involved in any union labor dispute nor, to the knowledge of the Company or any of its Subsidiaries, is any such dispute threatened. Neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that relations with their employees are good. No executive officer (as defined in Rule 501(f) of the 0000 Xxx) has notified the Company that such officer intends to leave the Company's employ or otherwise terminate such officer's employment with the Company.
l. Intellectual Property Rights. All patents,
patent applications, trademark registrations and applications for trademark
registration held by the Company are owned free and clear of all mortgages,
liens, charges or encumbrances whatsoever. No licenses have been granted with
respect to these items and the Company and its Subsidiaries do not have any
knowledge of any infringement by the Company or its Subsidiaries of trademark,
trade name rights, patents, patent rights, copyrights, inventions, licenses,
service names, service marks, service xxxx registrations, trade secret or other
similar rights of others, and, except as set forth on Schedule 3(l), there is no
claim, action or proceeding being made or brought against, or to the Company's
knowledge, being threatened against, the Company or its Subsidiaries regarding
trademark, trade name, patents, patent rights, invention, copyright, license,
service names, service marks, service xxxx registrations, trade secret or other
infringement; and the Company and its Subsidiaries are unaware of any facts or
circumstances which might give rise to any of the foregoing. The Company and its
Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their intellectual properties.
m. Environmental Laws. The Company and its Subsidiaries (i) are in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants ("ENVIRONMENTAL LAWS"), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance with all terms and conditions of any such permit, license or approval where, in each of the three foregoing cases, the failure to so comply would have, individually or in the aggregate, a Material Adverse Effect.
n. Title. The Company and its Subsidiaries have good and marketable title in fee simple to all real property and good and marketable title to all personal property owned by them which is material to the business of the Company and its Subsidiaries, in each case free and clear of all liens, encumbrances and defects except such as are described in Schedule 3(n) or such as do not materially affect the value of such property and do not interfere with the use made and proposed to be made of such property by the Company or any of its Subsidiaries. Any real property and facilities held under lease by the Company or any of its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its Subsidiaries.
o. Insurance. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has been refused any insurance coverage sought or applied for and neither the Company nor any such Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.
p. Regulatory Permits. The Company and its Subsidiaries have in full force and effect all certificates, approvals, authorizations and permits from the appropriate federal, state, local or foreign regulatory authorities and comparable foreign regulatory agencies, necessary to own, lease or operate their respective properties and assets and conduct their respective businesses, and neither the Company nor any such Subsidiary has received any notice of proceedings relating to the revocation or modification of any such certificate, approval, authorization or permit, except for such certificates, approvals, authorizations or permits which if not obtained, or such revocations or modifications which, would not have a Material Adverse Effect.
q. Internal Accounting Controls. The Company and each of its Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management's general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management's general or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
r. No Materially Adverse Contracts, Etc. Neither the Company nor any of its Subsidiaries is subject to any charter, corporate or other legal restriction, or any judgment, decree, order, rule or regulation which in the judgment of the Company's officers has or is expected in the future to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a party to any contract or agreement which in the judgment of the Company's officers has or is expected to have a Material Adverse Effect.
s. Tax Status. Except for the former Xxxxxx Productions, Inc.’s 2000 federal income tax return, and the Company’s consolidated 2001 federal income tax return, the Company and each of its Subsidiaries has made or filed all United States federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that the Company and each of its Subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provision reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. Except for unpaid federal withholding taxes, there are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company know of no basis for any such claim.
t. Certain Transactions. Except as set forth on Schedule 3(t) and in the SEC Documents filed at least ten days prior to the date hereof and except for arm's length transactions pursuant to which the Company makes payments in the ordinary course of business upon terms no less favorable than the Company could obtain from third parties and other than the grant of stock options disclosed on Schedule 3(c), none of the officers, directors, or employees of the Company is presently a party to any transaction with the Company or any of its Subsidiaries (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any corporation, partnership, trust or other entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee or partner.
u. Dilutive Effect. The Company understands and acknowledges that the number of shares of Common Stock issuable upon purchases pursuant to this Subscription Agreement will increase in certain circumstances including, but not necessarily limited to, the circumstance wherein the trading price of the Common Stock declines following the effective date of the registration statement covering the Common Stock underlying the Debentures (the “Effective Date”). The Company’s executive officers and directors have studied and fully understand the nature of the transactions contemplated by this Subscription Agreement and recognize that they have a potential dilutive effect. The board of directors of the Company has concluded, in its good faith business judgment, that such issuance is in the best interests of the Company. The Company specifically acknowledges that, subject to such limitations as are expressly set forth in the Transaction Documents, its obligation to issue shares of Common Stock upon purchases pursuant to this Subscription Agreement is absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.
v.
Right of First Refusal. The Company shall not, directly or indirectly,
without the prior written consent of Dutchess Private Equities Fund, L.P.,
offer, sell, grant any option to purchase, or otherwise dispose of (or announce
any offer, sale, grant or any option to purchase or other disposition) any of
its Common Stock or securities convertible into Common Stock at a price that is
less than the market price of the Common Stock at the time of issuance of such
security or investment (a "SUBSEQUENT FINANCING") for a period of one year after
the Effective Date, except (i) the granting of options or warrants to employees,
officers, directors and consultants, and the issuance of shares upon exercise of
options granted, under any stock option plan heretofore or hereinafter duly
adopted by the Company, (ii) shares issued upon exercise of any currently
outstanding warrants or options and upon conversion of any currently outstanding
convertible debenture or convertible preferred stock, in each case disclosed
pursuant to Section 3(c), (iii) securities issued in connection with the
capitalization or creation of a joint venture with a strategic partner, (iv)
shares issued to pay part or all of the purchase price for the acquisition by
the Company of another entity (which, for purposes of this clause (iv), shall
not include an individual or group of individuals), and (v) shares issued in a
bona fide public offering by the Company of its securities, and (vi) shares that
may be issued as a result of any outstanding rights offering between the Company
and its current stockholder, unless (A) the Company delivers to Dutchess
Private Equities Fund, L.P. a written notice (the "SUBSEQUENT FINANCING NOTICE")
of its intention to effect such Subsequent Financing, which Subsequent Financing
Notice shall describe in reasonable detail the proposed terms of such Subsequent
Financing, the amount of proceeds intended to be raised thereunder, the person
with whom such Subsequent Financing shall be effected, and attached to which
shall be a term sheet or similar document relating thereto and (B) Dutchess
Private Equities Fund, L.P. shall not have notified the Company by 5:00 p.m.
(New York time) on the fifth (5th) business day after its receipt of the
Subsequent Financing Notice of its willingness to provide, subject to completion
of documentation, financing to the Company on substantially the terms set forth
in the Subsequent Financing Notice. If Dutchess Private Equities Fund, L.P.
shall fail to notify the Company of its intention to enter into such
negotiations within such time period, then the Company may effect the Subsequent
Financing substantially upon the terms set forth in the Subsequent Financing
Notice; PROVIDED THAT the Company shall provide Dutchess Private Equities Fund,
L.P. with a second Subsequent Financing Notice, and Dutchess Private Equities
Fund, L.P. shall again have the right of first refusal set forth above in this
Section, if the Subsequent Financing subject to the initial Subsequent Financing
Notice shall not have been consummated for any reason on the terms set forth in
such Subsequent Financing Notice within thirty (30) business days after the date
of the initial Subsequent Financing Notice. The rights granted to Dutchess
Private Equities Fund, L.P. in this Section are not subject to any prior right
of first refusal given to any other person except as disclosed on Schedule
3(c).
w. Lock-up Period. The Company agrees to use its best efforts to have its officers, insiders, directors and affiliates refrain from selling Common Stock during the ninety (90) calendar day period following the date the registration statement for this Offering is declared effective.
w. Lock-up Period. The Company agrees to use its best efforts to have its officers, insiders, directors and affiliates refrain from selling Common Stock during the ninety (90) calendar day period following the date the registration statement for this Offering is declared effective.
4. COVENANTS
OF THE COMPANY
a. Best Efforts. The Company shall use its best efforts timely to satisfy each of the conditions to be satisfied by it as provided in this Subscription Agreement.
b.
Blue Sky. The Company shall, at its sole cost and expense, make all
filings and reports relating to the offer and sale of the Debentures and the
Common Stock underlying the Debentures as required under the applicable
securities or “Blue Sky” laws of such states of the United States as
specified by the Purchaser.
c. Reporting Status. Until the earlier of (i) the date that the Purchaser may sell all of the Common Stock underlying the shares acquired pursuant to this Subscription Agreement without restriction pursuant to Rule 144(k) promulgated under the 1933 Act (or successor thereto), or (ii) the date on which the Purchaser shall have sold all the Common Stock underlying the Debentures, the Company shall file all reports required to be filed with the SEC pursuant to the 1934 Act, and the Company shall not terminate its status as a reporting company under the 1934 Act.
d. Use of Proceeds. The Company will use the proceeds from the sale of the Debentures (excluding amounts paid by the Company for fees as set forth in the Transaction Documents) for general corporate and working capital purposes, but not for the payment of debt.
e. Financial Information. The Company agrees to make available to the Purchaser via XXXXX or other electronic means the following: (i) within five (5) business days after the filing thereof with the SEC, a copy of its Annual Reports on Form 10-KSB, its Quarterly Reports on Form 10-QSB, any Current Reports on Form 8-K and any Registration Statements or amendments filed pursuant to the 1933 Act; (ii) on the same day as the release thereof, facsimile copies of all press releases issued by the Company or any of its Subsidiaries, (iii) copies of any notices and other information made available or given to the shareholders of the Company generally, contemporaneously with the making available or giving thereof to the shareholders and (iv) within two (2) calendar days of filing or delivery thereof, copies of all documents filed with, and all correspondence sent to, the Principal Market, any securities exchange or market, or the National Association of Securities Dealers, Inc.
f. Reservation of Common Stock. Subject to the following sentence, the Company shall take all action necessary to at all times have authorized, and reserved for the purpose of issuance, a sufficient number of shares of Common Stock to provide for the issuance of the Common Stock underlying the Debentures. In the event that the Company determines that it does not have a sufficient number of authorized shares of Common Stock to reserve and keep available for issuance, the Company shall use its best efforts to increase the number of authorized shares of Common Stock by seeking shareholder approval for the authorization of such additional shares.
g. Listing. The Company shall promptly secure the listing of all of the Common Stock underlying the Debentures upon the Principal Market and each other national securities exchange and automated quotation system, if any, upon which shares of Common Stock are then listed (subject to official notice of issuance) and shall maintain, such listing. The Company shall maintain the Common Stock's authorization for quotation on the Principal Market, unless the Purchaser and the Company agree otherwise, and the Company shall use its best efforts to promptly make application for listing on the new Bulletin Board Exchange not later than ninety (90) calendar days after the date the Company receives its application in the mail. Neither the Company nor any of its Subsidiaries shall take any action which would be reasonably expected to result in the delisting or suspension of the Common Stock on the Principal Market (excluding suspensions of not more than one trading day resulting from business announcements by the Company). The Company shall promptly provide to the Purchaser copies of any notices it receives from the Principal Market regarding the continued eligibility of the Common Stock for listing on such automated quotation system or securities exchange. The Company shall pay all fees and expenses in connection with satisfying its obligations under this Section.
h. Transactions With Affiliates. The Company shall not, and shall cause each of its Subsidiaries not to, enter into, amend, modify or supplement, or permit any Subsidiary to enter into, amend, modify or supplement, any agreement, transaction, commitment or arrangement with any of its or any Subsidiary's officers, directors, persons who were officers or directors at any time during the previous two years, shareholders who beneficially own 5% or more of the Common Stock, or affiliates or with any individual related by blood, marriage or adoption to any such individual or with any entity in which any such entity or individual owns a 5% or more beneficial interest (each a “RELATED PARTY”), except for (i) customary employment arrangements and benefit programs on reasonable terms (including changes currently under discussion with the Company's Board of Directors concerning the compensation, to be payable in stock, of the Chairman of the Board), (ii) any agreement, transaction, commitment or arrangement on an arms-length basis on terms no less favorable than terms which would have been obtainable from a person other than such Related Party, or (iii) any agreement, transaction, commitment or arrangement which is approved by a majority of the disinterested directors of the Company. For purposes hereof, any director who is also an officer of the Company or any Subsidiary of the Company shall not be a disinterested director with respect to any such agreement, transaction, commitment or arrangement. “AFFILIATE” for purposes hereof means, with respect to any person or entity, another person or entity that, directly or indirectly, (i) has a 5% or more equity interest in that person or entity, (ii) has 5% or more common ownership with that person or entity, (iii) Controls that person or entity, or (iv) shares common control with that person or entity. “CONTROL” or "CONTROLS" for purposes hereof means that a person or entity has the power, direct or indirect, to conduct or govern the policies of another person or entity.
i. Intentionally deleted.
j. Corporate Existence. The Company shall use its best efforts to preserve and continue the corporate existence of the Company.
k. Notice of Certain
Events Affecting Registration. The Company shall promptly notify Purchaser
upon the occurrence of any of the following events in respect of a registration
statement or related prospectus covering the Common Stock underlying the
Debentures: (i) receipt of any request for additional information by the SEC or
any other federal or state governmental authority during the period of
effectiveness of the registration statement for amendments or supplements to the
registration statement or related prospectus; (ii) the issuance by the SEC or
any other federal or state governmental authority of any stop order suspending
the effectiveness of any registration statement or the initiation of any
proceedings for that purpose; (iii) receipt of any notification with respect to
the suspension of the qualification or exemption from qualification of any of
the Common Stock underlying the Debentures for sale in any jurisdiction or the
initiation or threatening of any proceeding for such purpose; (iv) the happening
of any event that makes any statement made in such registration statement or
related prospectus or any document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires the making
of any changes in the registration statement, related prospectus or documents so
that, in the case of a registration statement, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein or necessary to make the statements therein not misleading, and
that in the case of the related prospectus, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be
stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and (v) the Company's
reasonable determination that a post-effective amendment to the registration
statement would be appropriate, and the Company shall promptly make available to
Purchaser any such supplement or amendment to the related prospectus.
l. Indemnification.
In consideration of the Purchaser’s execution and delivery of the this
Agreement and the Registration Rights Agreement and acquiring the Debentures
hereunder and in addition to all of the Company's other obligations under the
Transaction Documents, the Company shall defend, protect, indemnify and hold
harmless the Purchaser and all of their shareholders, officers, directors,
employees and direct or indirect investors and any of the foregoing person's
agents or other representatives (including, without limitation, those retained
in connection with the transactions contemplated by this Agreement)
(collectively, the "Indemnitees") from and against any and all actions, causes
of action, suits, claims, losses, costs, penalties, fees, liabilities and
damages, and expenses in connection therewith (irrespective of whether any such
Indemnitee is a party to the action for which indemnification hereunder is
sought), and including reasonable attorneys' fees and disbursements (the
“Indemnified Liabilities”), incurred by any Indemnitee as a result
of, or arising out of, or relating to (i) any misrepresentation or breach of any
representation or warranty made by the Company in the Transaction Documents or
any other certificate, instrument or document contemplated hereby or thereby,
(ii) any breach of any covenant, agreement or obligation of the Company
contained in the Transaction Documents or any other certificate, instrument or
document contemplated hereby or thereby, (iii) any cause of action, suit or
claim brought or made against such Indemnitee by a third party and arising out
of or resulting from the execution, delivery, performance or enforcement of the
Transaction Documents or any other certificate, instrument or document
contemplated hereby or thereby, (iv) any transaction financed or to be financed
in whole or in part, directly or indirectly, with the proceeds of the issuance
of the Debentures or (v) the status of the Purchaser as an investor in the
Company, except insofar as any such untrue statement, alleged untrue statement,
omission or alleged omission is made in reliance upon and in conformity with
written information furnished to the Company by the Purchaser which is
specifically intended by the Purchaser for use in the preparation of any such
Registration Statement, preliminary prospectus or prospectus. To the extent that
the foregoing undertaking by the Company may be unenforceable for any reason,
the Company shall make the maximum contribution to the payment and satisfaction
of each of the Indemnified Liabilities which is permissible under applicable
law. The indemnity provisions contained herein shall be in addition to any cause
of action or similar rights the Purchaser may have, and any liabilities to which
the Purchaser may be subject.
m. Reimbursement. If (i) Purchaser, other than by reason of its gross negligence or willful misconduct, becomes involved in any capacity in any action, proceeding or investigation brought by any shareholder of the Company, in connection with or as a result of the consummation of the transactions contemplated by the Transaction Documents, or if Purchaser is impleaded in any such action, proceeding or investigation by any person, or (ii) Purchaser, other than by reason of its gross negligence or willful misconduct or by reason of its trading of the Common Stock in a manner that is illegal under the federal securities laws, becomes involved in any capacity in any action, proceeding or investigation brought by the SEC against or involving the Company or in connection with or as a result of the consummation of the transactions contemplated by the Transaction Documents, or if Purchaser is impleaded in any such action, proceeding or investigation by any person, then in any such case, the Company will reimburse Purchaser for its reasonable legal and other expenses (including the cost of any investigation and preparation) incurred in connection therewith, as such expenses are incurred. In addition, other than with respect to any matter in which Purchaser is a named party, the Company will pay to Purchaser the charges, as reasonably determined by Purchaser, for the time of any officers or employees of Purchaser devoted to appearing and preparing to appear as witnesses, assisting in preparation for hearings, trials or pretrial matters, or otherwise with respect to inquiries, hearing, trials, and other proceedings relating to the subject matter of this Subscription Agreement. The reimbursement obligations of the Company under this section shall be in addition to any liability which the Company may otherwise have, shall extend upon the same terms and conditions to any affiliates of Purchaser that are actually named in such action, proceeding or investigation, and partners, directors, agents, employees, attorneys, accountants, auditors and controlling persons (if any), as the case may be, of Purchaser and any such affiliate, and shall be binding upon and inure to the benefit of any successors of the Company, Purchaser and any such affiliate and any such person.
5. LIMITATION ON AMOUNT OF CONVERSION AND OWNERSHIP.
Notwithstanding
anything to the contrary in this Agreement, in no event shall the Purchaser be
entitled to convert any of the Debentures to the extent that, after such
conversion, that number of shares of Common Stock, which when added to the sum
of the number of Debentures beneficially owned, (as such term is defined under
Section 13(d) and Rule 13d-3 of the Securities Exchange Act of 1934 (the
“1934 ACT”)), by the Purchaser, would exceed 4.99% of the number of
shares of Common Stock outstanding on the Conversion Date (as that term is
defined in the Debenture), as determined in accordance with Rule 13d-1(j) of the
1934 Act. In no event shall the Purchaser purchase shares of the Common Stock
other than pursuant to this Subscription Agreement and the Debenture until such
date as the Purchaser has fully converted the Debentures into Common Stock.
6. OPINION LETTER/BOARD RESOLUTION
Prior to or on the Closing Date the Company shall deliver to the Escrow Agent an opinion letter signed by counsel for the Company in the form attached hereto as Exhibit D. Also, prior to or on the Closing Date the Company shall deliver to the Escrow Agent a signed Board Resolution authorizing this Offering, which shall be attached hereto as Exhibit E.
7. DELIVERY INSTRUCTIONS; FEES
The Debentures being purchased hereunder shall be delivered to Xxxxxx X. XxXxxxx, Esq. as Escrow Agent, who will hold them in escrow until the Closing Date at which time funds (less escrow fees, attorneys fees and placement fees) will be wired to the Company and the Debentures will be delivered to the Purchaser, per the Purchaser’s instructions.
Dutchess Private Equities Fund, L.P. shall receive a commitment fee of $25,000 upon the initial closing and an additional $20,000 upon the second closing. Upon closing Xxxxxx X. XxXxxxx, Esq. shall receive from escrow the sum of $10,000 for document preparation.
8. UNDERSTANDINGS.
The undersigned understands, acknowledges and agrees with the Company as follows:
FOR ALL SUBSCRIBERS:
a. This Subscription may be rejected, in whole or in part, by the Company in its sole and absolute discretion at any time before the date set for closing unless the Company has given notice of acceptance of the undersigned’s subscription by signing this Subscription Agreement and delivering it to Purchaser.
b. No U.S. federal or state agency or any agency of any
other jurisdiction has made any finding or determination as to the fairness of
the terms of the Offering for investment nor any recommendation or endorsement
of the Debentures or the Company.
c. The representations, warranties and agreements of the undersigned and the Company contained herein shall be true and correct in all material respects on and as of the date of the sale of the Debentures as if made on and as of such date and shall survive the execution and delivery of this Subscription Agreement and the purchase of the Debentures.
d. In making an investment decision, purchasers must rely on their own examination of the company and the terms of the offering, including the merits and risks involved. The shares have not been recommended by any federal or state securities commission or regulatory authority. Furthermore, the foregoing authorities have not confirmed the accuracy or determined the adequacy of this document. Any representation to the contrary is a criminal offense.
e. The Offering is intended to be exempt from registration by virtue of Section 4(2) of the 1933 Act and the provisions of Regulation D thereunder, which is in part dependent upon the truth, completeness and accuracy of the statements made by the undersigned herein and in the Questionnaire.
f. It is understood that in order not to jeopardize the Offering’s exempt status under Section 4(2) of the 1933 Act and Regulation D, any purchaser may, at a minimum, be required to fulfill the investor suitability requirements thereunder.
g. The shares may not be resold except as permitted under the securities act and applicable state securities laws, pursuant to registration or exemption therefrom. Purchasers should be aware that they will be required to bear the financial risks of this investment for an indefinite period of time.
9. SUBMISSION TO JURISDICTION
a. Forum Selection and Consent to Jurisdiction. Any litigation based thereon, or arising out of, under, or in connection with, this Agreement or any course of conduct, course of dealing, statements (whether oral or written) or actions of the Company or Purchaser shall be brought and maintained exclusively in the courts of the state of New York. The Company hereby expressly and irrevocably submits to the jurisdiction of the state and federal Courts of the state of New York for the purpose of any such litigation as set forth above and irrevocably agrees to be bound by any final judgment rendered thereby in connection with such litigation. The Company further irrevocably consents to the service of process by registered mail, postage prepaid, or by personal service within or without the State of New York. The Company hereby expressly and irrevocably waives, to the fullest extent permitted by law, any objection which it may have or hereafter may have to the laying of venue of any such litigation brought in any such court referred to above and any claim that any such litigation has been brought in any inconvenient forum. To the extent that the Company has or hereafter may acquire any immunity from jurisdiction of any court or from any legal process (whether through service or notice, attachment prior to judgment, attachment in aid of execution or otherwise) with respect to itself or its property. The Company hereby irrevocably waives such immunity in respect of its obligations under this agreement and the other loan documents.
b. Waiver of Jury Trial. The Purchaser and the Company hereby knowingly, voluntarily and intentionally waive any rights they may have to a trial by jury in respect of any litigation based hereon, or arising out of, under, or in connection with, this agreement, or any course of conduct, course of dealing, statements (whether oral or written) or actions of the Purchaser or the Company. The Company acknowledges and agrees that it has received full and sufficient consideration for this provision and that this provision is a material inducement for the Purchaser entering into this agreement.
c. Submission To Jurisdiction. Any legal action or proceeding in connection with this Agreement or the performance hereof may be brought in the state and federal courts located in New York, and the parties hereby irrevocably submit to the non-exclusive jurisdiction of such courts for the purpose of any such action or proceeding.
10. MISCELLANEOUS.
a. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Subscription Agreement must be in writing and will be deemed to have been delivered (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided a confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one (1) day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses and facsimile numbers for such communications shall be:
If to the Company:
VirTra Systems, Inc.
000 Xxxxx Xxxxxx
Xxxxxxxxx, XX 00000
Attention: L. Xxxxx Xxxxx, CEO and CFO
000 Xxxxx Xxxxxx
Xxxxxxxxx, XX 00000
Attention: L. Xxxxx Xxxxx, CEO and CFO
Telephone: 000-000-0000
Facsimile: 000-000-0000
With a copy to:
Xxxxx Xxxxxx & Xxxxx LLP
000 Xxxxxxx Xxxxxx
00xx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxxx X. Xxxxxx, Esq.
Telephone: 000-000-0000
Facsimile: 212-684-9022
If to the Investor:
At the address listed in the Questionnaire.
With a copy to:
Xxxxxx X. XxXxxxx, Esq.
00 Xxxxxx
Xxxxxx, Xxxxx 000
Xxx Xxxxxx, XX 00000
Telephone No.: 000-000-0000
Telecopier No.: 000-000-0000
Xxx Xxxxxx, XX 00000
Telephone No.: 000-000-0000
Telecopier No.: 000-000-0000
Each party shall provide five (5) business days prior notice to the other party of any change in address, phone number or facsimile number.
b. All pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine, impersonal, singular or plural, as the identity of the person or persons may require.
c. Neither this Subscription Agreement nor any provision hereof shall be waived, modified, changed, discharged, terminated, revoked or canceled, except by an instrument in writing signed by the party effecting the same against whom any change, discharge or termination is sought.
d. Notices required or permitted to be given hereunder shall be in writing and shall be deemed to be sufficiently given when personally delivered or sent by facsimile transmission: (i) if to the Company, at it’s executive offices or (ii) if to the Purchaser, at the address for correspondence set forth in the Questionnaire, or at such other address as may have been specified by written notice given in accordance with this paragraph.
e. This Subscription Agreement shall be enforced, governed and construed in all respects in accordance with the laws of the State of Texas, as such laws are applied by Texas courts to agreements entered into, and to be performed in, Texas by and between residents of Texas, and shall be binding upon the undersigned, the undersigned's heirs, estate and legal representatives and shall inure to the benefit of the Company and its successors. If any provision of this Subscription Agreement is invalid or unenforceable under any applicable statue or rule of law, then such provisions shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any provision hereof that may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision hereof.
f. This Agreement shall not be assignable.
g. This Subscription Agreement, together with Exhibits
A, B, C, D, E and F attached hereto and made a part hereof, constitute the
entire agreement between the parties hereto with respect to the subject matter
hereof and may be amended only by a writing executed by both parties
hereto.
h. This
Subscription Agreement may be executed in two or more counterparts, all of which
taken together shall constitute one instrument. Execution and delivery of this
Subscription Agreement by exchange of facsimile copies bearing the facsimile
signature of a party shall constitute a valid and binding execution and delivery
of this Subscription Agreement by such party. Such facsimile copies shall
constitute enforceable original documents.
[BALANCE OF PAGE INTENTIONALLY LEFT BLANK)
VIRTRA
SYSTEMS, INC.
QUESTIONNAIRE
QUESTIONNAIRE
The information contained in this Questionnaire is being furnished in order to determine whether the undersigned’s subscription to purchase the Debentures described in the Subscription Agreement may be accepted.
ALL INFORMATION CONTAINED IN THIS QUESTIONNAIRE WILL BE TREATED CONFIDENTIALLY. The undersigned understands, however, that the Company may present this Questionnaire to such parties as it deems appropriate if called upon to establish that the proposed offer and sale of the Securities is exempt from registration under the 1933 Act, as amended. Further, the undersigned understands that the offering is required to be reported to the Securities and Exchange Commission, NASDAQ and to various state securities and “blue sky” regulators.
IN ADDITION TO SIGNING THE SIGNATURE PAGE, IF REQUESTED BY THE COMPANY, THE UNDERSIGNED MUST COMPLETE FORM W-9.
I. PLEASE CHECK EACH OF THE STATEMENTS BELOW THAT APPLIES.
1. The
undersigned: (a) has total assets in excess of $5,000,000; (b) was not formed
for the specific purpose of acquiring the securities and (c) has its principal
place of business in ___________.
2. The
undersigned is a natural person whose individual net worth* or joint net worth
with his or her spouse exceeds $1,000,000.
3. The
undersigned is a natural person who had an individual income* in excess of
$200,000 in each of the two most recent years and who reasonably expects an
individual income in excess of $200,000 in the current year. Such income is
solely that of the undersigned and excludes the income of the
undersigned’s spouse.
4. The
undersigned is a natural person who, together with his or her spouse, has had a
joint income* in excess of $300,000 in each of of the two most recent years and
who reasonably expects a joint income in excess of $300,000 in the current
year.
* For purposes of this Questionnaire, the term
“net worth” means the excess of total assets over total liabilities.
In determining “income”, an investor should add to his or her
adjusted gross income any amounts attributable to tax-exempt income received,
losses claimed as a limited partner in any limited partnership, deductions
claimed for depletion, contributions to XXX or Xxxxx retirement plan, alimony
payments and any amount by which income from long-term capital gains has been
reduced in arriving at adjusted gross income.
5. The undersigned is:
(a) a
bank as defined in Section 3(a)(2) of the 1933 Act; or
(b) a
savings and loan association or other institution as defined in Section
3(a)(5)(A) of the 1933 Act whether acting in its individual or fiduciary
capacity; or
(c) a
broker or dealer registered pursuant to Section 15 of the 1934 Act;
or
(d) an
insurance company as defined in Section 2(13) of the 1933 Act; or
(e) An
investment company registered under the Investment Company Act of 1940 or a
business development company as defined in Section 2(a)(48) of the Investment
Company Act of 1940; or
(f) a
small business investment company licensed by the U.S. Small Business
Administration under Section 301 (c) or (d) of the Small Business Investment Act
of 1958; or
6. The
undersigned is an entity in which all of the equity owners are accredited
investors.
II. INVESTOR
INFORMATION.
(a) IF
THE UNDERSIGNED IS AN INDIVIDUAL:
Name
_________________________________________
Street
Address __________________________________
City,
State, Zip Code _____________________________
Phone
____________________ Fax _________________
Social
Security Number ___________________________
Send
Correspondence to:
_______________________________________________
_______________________________________________
_______________________________________________
(b) IF
THE UNDERSIGNED IS NOT AN INDIVIDUAL:
Name
of Entity __________________________________
Person’s
Name ___________________ Title___________
State
of Organization ______________________________
Principal
Business Address _________________________
City,
State, Zip Code ______________________________
Taxpayer
Identification Number _____________________
Phone
____________________ Fax _________________
Send
Correspondence to:
_______________________________________________
_______________________________________________
_______________________________________________
VIRTRA
SYSTEMS, INC.
SIGNATURE PAGE
SIGNATURE PAGE
Your signature on this Signature Page evidences your agreement to be bound by the Questionnaire, Subscription Agreement and Registration Rights Agreement.
1. The undersigned hereby represents that (a) the information contained in the Questionnaire is complete and accurate and (b) the undersigned will notify VIRTRA SYSTEMS, INC. immediately if any material change in any of the information occurs prior to the acceptance of the undersigned’s subscription and will promptly send VIRTRA SYSTEMS, INC. written confirmation of such change.
2. The undersigned signatory hereby certifies that he/she has read and understands the Subscription Agreement and Questionnaire, and the representations made by the undersigned in the Subscription Agreement and Questionnaire are true and accurate.
______________________________ ________________________
Amount of Debentures being purchased Date
By: _____________________
(Signature)
Name:
__________________
(Please Type or Print)
Title:
____________________
(Please Type or
Print)
COMPANY
ACCEPTANCE PAGE
This Subscription Agreement
accepted and agreed
to this ____ day of July, 2002.
VIRTRA SYSTEMS, INC.
By__________________________________
L. Xxxxx Xxxxx, CEO & CFO
to this ____ day of July, 2002.
VIRTRA SYSTEMS, INC.
By__________________________________
L. Xxxxx Xxxxx, CEO & CFO
Exhibit
A
NOTICE OF CONVERSION
(To be Executed by the Registered Owner in order to Convert Debenture)
NOTICE OF CONVERSION
(To be Executed by the Registered Owner in order to Convert Debenture)
The undersigned hereby irrevocably elects, as of
________________, to convert $________________ of its convertible debenture (the
“Debenture”) into Common Stock of VIRTRA SYSTEMS, INC. (the
“Company”) according to the conditions set forth in the Debenture
issued by the Company. This conversion is being made for an immediate
sale.
Date of Conversion________________________________________________
Applicable Conversion Price________________________________________
Number of Debentures Issuable upon this Conversion_______________________
Name(Print)_____________________________________________________
Address________________________________________________________
Phone_________________________ Fax______________________________
Date of Conversion________________________________________________
Applicable Conversion Price________________________________________
Number of Debentures Issuable upon this Conversion_______________________
Name(Print)_____________________________________________________
Address________________________________________________________
Phone_________________________ Fax______________________________
By:_______________________________________
EXHIBIT D
Purchasers of [Company] [Describe Securities] _______________, 2001
Re: VirTra
Systems, Inc.
Ladies and Gentlemen:
As counsel to VirTra Systems, Inc. (the “Company”), we are familiar with its Articles of Incorporation and Bylaws and with the corporate proceedings taken by it in connection with the proposed issuance and sale of convertible debentures (the “Securities”) pursuant to the related Subscription Agreement (including all Exhibits and Appendices thereto) (collectively the “Agreements”).
We have been furnished with copies, certified or otherwise identified to our satisfaction, of the Agreements, and have examined such other documents, agreements and records as we deemed necessary to render the opinions set forth below.
In conducting our examination, we have assumed the following: (i) that each of the Agreements has been executed by each of the parties thereto in the same form as the forms which we have examined, (ii) the genuineness of all signatures, the legal capacity of natural persons, the authenticity and accuracy of all documents submitted to us as originals, and the conformity to originals of all documents submitted to us as copies, (iii) that each of the Agreements has been duly and validly authorized, executed and delivered by the party or parties thereto other than the Company, and (iv) that each of the Agreements constitutes the valid and binding agreement of the party or parties thereto other than the Company, enforceable against such party or parties in accordance with the Agreements’ terms.
Based upon the subject to the foregoing, we are of the opinion that:
1. The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of __________, and has all requisite corporate power and authority to own its properties and conduct its business.
2. The authorized capital stock of the Company consists of _______ shares of Common Stock, ________ par value per share, (“Common Stock”) and ______________ Preferred Stock, par value $________ per share; [describe classes if applicable]
3. The Common Stock is registered pursuant to Section 12(b) or Section 12(g) of the Securities Exchange Act of 1934, as amended and the Company has timely filed all the material required to be filed pursuant to Sections 13(a) or 15(d) of such Act for a period of at least twelve months preceding the date hereof;
4. When duly countersigned by the Company’s transfer agent and registrar, and delivered to you or upon your order against payment of the agreed consideration therefor in accordance with the provisions of the Agreements, the Securities [and any Common Stock to be issued upon the conversion of the Securities] as described in the Agreements represented thereby will be duly authorized and validly issued, fully paid and nonassessable;
5 The Company has the requisite corporate power and authority to enter into the Subscription Agreement and to sell and deliver the Securities and the Common Stock to be issued upon the conversion of the Securities as described in the Agreements; each of the Agreements has been duly and validly authorized by all necessary corporate action by the Company to our knowledge, no approval of any governmental or other body is required for the execution and delivery of each of the Agreements by the Company or the consummation of the transactions contemplated thereby; each of the Agreements has been duly and validly executed and delivered by and on behalf of the Company, and is a valid and binding agreement of the Company, enforceable in accordance with its terms, except as enforceability may be limited by general equitable principles, bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws affecting creditors rights generally, and except as to compliance with federal, state, and foreign securities laws, as to which no opinion is expressed;
6. To the best of our knowledge, after due inquiry, the execution, delivery and performance of the Subscription Agreement and Securities by the Company and the performance of its obligations thereunder do not and will not constitute a breach or violation of any of the terms and provisions of, or constitute a default under or conflict with or violate any provision of (i) the Company’s Certificate of Incorporation or By-Laws, (ii) any indenture, mortgage, deed of trust, agreement or other instrument to which the Company is party or by which it or any of its property is bound, (iii) any applicable statute or regulation or as other, (iv) or any judgment, decree or order of any court or governmental body having jurisdiction over the Company or any of its property.
7. To the best of our knowledge, after due inquiry, there is no pending or threatened litigation, investigation or other proceedings against the Company [except as described in Exhibit A hereto].
8. The Company complies with the eligibility requirements for the use of Form SB-2, under the Securities Act of 1933, as amended.
This opinion is rendered only with regard to the matters set out in the numbered paragraphs above. No other opinions are intended nor should they be inferred. This opinion is based solely upon the laws of the United States and the State of New York and does not include an interpretation or statement concerning the laws of any other state or jurisdiction. Insofar as the enforceability of the Subscription Agreement and Securities may be governed by the laws of other states, we have assumed that such laws are identical in all respects to the laws of the State of New York .
The opinions expressed herein are given to you solely for your use in connection with the transaction contemplated by the Subscription Agreement and Securities and may not be relied upon by any other person or entity or for any other purpose without our prior consent.
Very truly yours,
By: _____________________
LIST OF
EXHIBITS
-----------------
-----------------
EXHIBIT
A Notice of Conversion
EXHIBIT
B Registration Rights Agreement
EXHIBIT
C Debenture
EXHIBIT
D Opinion of Company's Counsel
EXHIBIT
E Board Resolution
EXHIBIT
F Warrant
LIST OF
SCHEDULES
-----------------
-----------------
Schedule 3(a) Subsidiaries
Schedule 3(c) Capitalization
Schedule 3(e) Conflicts
Schedule 3(g) Material Changes
Schedule 3(h) Litigation
Schedule 3(l) Intellectual Property
Schedule 3(n) Liens
Schedule 3(t) Certain Transactions
SCHEDULE 3(a)
SUBSIDIARIES
None.
SCHEDULE 3(c)
CAPITALIZATION
OPTIONS
In 1997 and 1998 the Company granted incentive
stock options to certain officers and members of the Company’s board of
directors (L. Xxxxx Xxxxx and Xxxx Xxxxxxxx) to purchase 1,166,000 shares of the
Company’s common stock at par value of $.005 per share. These options are
exercisable based on various levels of the Company’s stock price: (i)
options to purchase 222,000 shares at par value are exercisable if the
Company’s stock is trading at $1.50 per share; (ii) options to purchase
472,000 shares at par value are exercisable if the Company’s stock is
trading at $3.00 per share; (iii) options to purchase 222,000 shares at par
value are exercisable if the Company’s stock is trading at $4.50 per
share; and (iv) options to purchase 250,000 shares at par value are exercisable
if the Company’s common stock is trading at $5.00 per share. There is no
expiration date on these options.
In 1997 and 1998 in connection
with the convertible notes payable to certain stockholders the Company granted
options to purchase 75,000 shares of its common stock, at its par value of $.005
per share, to these convertible note holders.
In July 2001 options to purchase 150,000 shares
of common stock were granted to a consultant (Magnum Financial Corporation) as
inducement for services to be provided to the Company. The options are
exercisable at (i) the closing bid price per share on the date of grant for
50,000 shares; (ii) the closing bid price at the date of grant plus $.50 per
share for 50,000 shares; and (iii) the closing bid price at the date of grant
plus $1.00 per share for 50,000 shares. These options expire five years from
the date of grant. The Company deemed the value of these options to be
immaterial at the date of grant.
On June 1, 2001 the Company
granted options to a director (Xxxxx Xxxxxxxx) to purchase 100,000 shares of the
Company’s common stock at $0.49 per share, which was the fair market value
of the common stock on the date of grant. The options are exercisable on June
1, 2002.
In September 2001 the Company
granted incentive stock options to certain officers and members of the
Company’s board of directors (Xxx Xxxxxx, Xxxxx Xxxxxxxx, and Xxxx Xxxxx)
to purchase 1,499,000 shares of the Company’s common stock at par value of
$.005 per share. These options are exercisable based on various levels of the
Company’s stock price: (i) options to purchase 333,000 shares at par value
are exercisable if the Company’s stock is trading at $1.50 per share; (ii)
options to purchase 583,000 shares at par value are exercisable if the
Company’s stock is trading at $3.00 per share; (iii) options to purchase
333,000 shares at par value are exercisable if the Company’s stock is
trading at $4.50 per share; and (iv) options to purchase 250,000 shares at par
value are exercisable if the Company’s common stock is trading at $5.00
per share. There is no expiration date on these options.
In
September 2001, the Company’s stockholders amended the 2000 Incentive
Stock Option Plan (the “Plan”). The stockholders have authorized
6,000,000 shares for the Plan and options granted under the Plan may be either
incentive stock options or non-statutory stock options subject to certain
restrictions as specified in the Plan. During the year ended December 31, 2001
no options were granted under this Plan; however, the Company has recently
issued 175,000 of these options to certain key employees.
WARRANTS
04/14/00 245,000 (@ ..625) (Xxxxxx commitment)
04/14/00 245,000 (@ 1.000) (Xxxxxx commitment)
10/26/00 3933 (@ .418) (Xxxxxx put #1)
01/02/01 1694 (@ .165) (Xxxxxx put #2)
03/08/01 1076 (@ .275) (Xxxxxx put #3)
496,703
Piggyback Rights
GALACTIC, LTD. HAS PIGGY BACK RIGHTS ON 325,000 COMMON
SHARES
INSTITUTIONAL CAPITAL FINANCE HAS PIGGY BACK RIGHTS ON 100,000 COMMON SHARES
INSTITUTIONAL CAPITAL FINANCE HAS PIGGY BACK RIGHTS ON 100,000 COMMON SHARES
SCHEDULE 3(e)
CONFLICTS
Notes payable consist of the
following at December 31, 2001:
Notes payable
to a bank, bearing interest ranging from the prime rate (4.75% at December 31,
2001) to the prime rate plus 2% per year and due in average monthly payments of
approximately $31,000, including interest, through November 2002. These notes
are collateralized by certain equipment, licensing rights and by the personal
guarantees of officers/stockholders of the Company.
|
$
559,474
|
Notes payable
to banks, bearing interest from 6.75% to 9.5% per year, interest due monthly
and principal due on demand. These notes are not collateralized but are
guaranteed by officers/stockholders of the Company. Effective January 17, 2002,
certain of these notes were refinanced into a single note which bears interest
at the prime rate (4.75% at December 31, 2001) plus 1.5%, due in 36 monthly
installments of $8,824 and collateralized by an office building owned by an
officer/stockholder of the Company.
|
250,000
|
Notes payable
to third party entities and individuals bearing interest at a stated rate of 10%
payable semi- annually with principal due three years after issuance of the
note, which ranges from October 2001 to March 2002. These notes are not
collateralized. In connec- tion with the funding of these notes, Xxxxxx issued a
total of 412,500 shares of its common stock as equity attachments to the note
holders and to pay debt is- suance costs. Accordingly, the actual weighted
average interest rate on these notes, including the effect of the issuance of
common stock and the payment of debt issuance costs, was approximately
16%.
|
250,000
|
Note payable
to a financing entity, due on demand, non- interest bearing. This note is not
collateralized.
|
19,990
|
|
|
Total notes payable
|
$1,079,464
|
|
|
The notes payable to banks
contain various financial and non-financial covenants, which require the
Company, among other things, to maintain certain levels of stockholders’
equity and to comply with certain financial ratios. The Company was in
violation of these covenants as of December 31, 2001 and the banks could demand
full payment of all principal and interest.
|
Notes Payable-Stockholders
Notes payable to stockholders
consisted of the following at December 31, 2001:
Convertible
notes payable to stockholders, principal and interest due on demand, accruing
interest at 12% per year. These notes are collateralized by certain equipment
and contain a provision to convert the note to common stock.
|
$
100,000
|
Note payable
to a stockholder, principal and interest due on demand, interest accrues at 10%
per year. This note is not collateralized.
|
194,031
|
Notes payable
to stockholders, non-interest bearing with principal due on demand. These notes
are not collateralized.
|
416,500
|
Total notes payable to
stockholders
|
$
710,531
|
All notes due to stockholders
were in default as of December 31, 2001. Convertible notes payable to
stockholders in the amount of $100,000 were issued by the Company in increments
of $10,000 having an original maturity date of May 10, 1998. The holder of each
$10,000 of convertible note has a non-assignable option to purchase 7,500 shares
of common stock at par value. Alternately, each holder has the right to convert
their convertible note to equity in the form of 12,500 shares of restricted
common stock. None of the notes have been converted.
Of the $416,500 of notes payable
without interest described above, a $103,500 note provides for a per diem
issuance of common stock as penalty for late payments. As of December 31, 2001,
the per diem issuance would be in excess of 5,800,000 shares of the
Company’s common stock. The Company has received an opinion from counsel
that the penalty provisions are unenforceable as illegal usury under applicable
Texas law. However, there has not been any litigation between the Company and
the holder of the note as to this issue, and in the absence of a court decision
directly applicable to the parties, there remains at least some risk that the
opinion of counsel could be wrong. According to legal counsel there is no
likelihood of a sustainable assessment of the per diem late penalty. Therefore,
no provision for such charges has been provided.
Obligations Under Product Financing Arrangements
In financing the production of
its arcade equipment, the Company has entered into agreements whereby an entity
or individual advances funds to the Company to produce specific arcade
equipment. Under this arrangement, the Company has agreed to make monthly
payments of a specified amount for three years, with an automatic renewal for an
additional three years unless canceled in writing, from the origination date as
specified in the agreement. In addition, the entity or individual advancing the
funds has the right to exercise a buy-out whereby the Company has 180 days to
repay the obligation upon exercise of the buy-out. Interest is payable monthly
at an annual rate of approximately 16%.
In connection with these
financing arrangements, the Company has incurred debt issuance costs of
approximately 21% of the total obligation. These costs are being amortized over
a three year period using the interest method resulting in an effective annual
interest rate of approximately 29% on these obligations.
Obligations under these product
financing arrangements consist of the following at December 31, 2001:
Contractual balance
|
$4,569,796
|
Less: unamortized debt issuance
costs
|
(215,446)
|
Total obligation
|
$4,354,350
|
As of December 31, 2001, the
Company was in default of its obligations under the product financing
arrangements. The Company has not made any interest payments on these
obligations since September 2001 and has received notices from various
individuals and entities requesting buyouts of approximately $1,350,000 as of
December 31, 2001.
SCHEDULE 3(g) MATERIAL CHANGES
NONE
SCHEDULE 3(h)
LITIGATION
In January, 1999, the Company brought suit in the 000xx
Xxxxxxxx Xxxxx xx Xxxxxxx Xxxxxx, Xxxxx, against Xxxxxx Xxxxx Xxxxx, III, the
Company's former president. In the suit, the Company claims that Xx. Xxxxx,
while president of the Company, misappropriated funds by paying himself
consulting fees although no meaningful services were performed for the Company,
and that he threatened, without justification, to attempt to rescind the March
1997 stock-for-stock transaction in which the Company acquired the
brewpub/microbrewery operation from First Brewery of Dallas, Inc. In the suit,
the Company is asking for 1) a declaratory judgment that the March, 1997
agreement is a valid and binding agreement, 2) an injunction to prevent Xxxxx
from selling his shares in the Company, and 3) damages for misappropriation of
the Company's funds. As permitted under Texas law, the Company has not specified
in its petition the amount of damages the Company wants from Xx. Xxxxx. On May
18, 2000, Xxxxx counterclaimed against the Company and filed a third-party suit
against L. Xxxxx Xxxxx, the Company's chief executive officer. In his
counterclaim, Xxxxx claims that 1) Xxxxx made false representations in
connection with the stock-for-stock transaction in March of 1997 between the
shareholders of the former First Brewery of Dallas, Inc. and the Company, 2)
that Xxxxx breached his fiduciary duties to the Company's shareholders, and 3)
that the Company failed to pay Xxxxx for services he claims he rendered to the
Company. The Company believes the counterclaim and third-party action are
groundless and are brought in bad faith. The Company has vigorously defended the
claims, and is asking for sanctions against Xxxxx'x attorney for bringing the
groundless causes of action. The case is currently in pre-trial discovery. Xxxxx
has recently proposed a “walk-away” settlement.
SCHEDULE 3(l) INTELLECTUAL PROPERTY
NONE
SCHEDULE 3(n) LIENS
ARIZONA
BUSINESS BANK HAS A BLANKET LIEN ON THE ASSETS OF THE FORMER XXXXXX
PRODUCTIONS,
INC.
SCHEDULE 3(t) CERTAIN TRANSACTIONS